Please login to the form below

Autolus

This page shows the latest Autolus news and features for those working in and with pharma, biotech and healthcare.

Bicycle Therapeutics looks to raise $86m with IPO

In November last year, gene therapy specialist Orchard Therapeutics raised over $200m, while CAR-T biotech Autolus generated $150m from its IPO in June.

Latest news

CAR-T player Autolus seeks $100m from follow-on financing

After a $100m initial public offering last year, Autolus is sitting on upwards of $200m ahead of the follow-on financing. ... to raise additional capital in order to develop and commercialize our product candidates,” said Autolus in an filing with the
Autolus’ next-gen CAR-T looks promising in ALL

Safety profile could bring greater market potential. UK biotech Autolus seems to be on track to develop a next generation of safer and equally, if not more, efficacious CAR-T therapies. ... Autolus is hoping that AUTO1 will change that, and its first
Novartis and Syncona back new Swiss biotech Anaveon

Autolus, which raised $150m in its IPO last June.
UK biotech booms in 2018, despite Brexit worries

Industry attracted a record-breaking £2.2bn in investment last year
UK’s genomics leadership attracts IQVIA investment, regardless of Brexit

Roche, Celgene and Autolus.

More from news
Approximately 5 fully matching, plus 9 partially matching documents found.

Latest appointments

Former Roche development head joins Asana advisory board

The founder of KAPital Consulting, Dr Dhingra currently serves on the boards of Exosome Diagnostics as chairman of the board, Advanced Accelerator Applications, Five Prime and Autolus.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

Understanding the evolving CAR-T market

More than 500 CAR-Ts are in development, making competition fierce. Earlier this year Autolus was forced to delay and even discontinue molecules in its CAR-T pipeline due to both ... The clinical data readout for the AUTO5 trial showed that it “may not

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Director: £Competitive Salary

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Client Services Director - Digital MedComms: £60000 - £80000 per annum, Benefits: Pension, healthcare, dedicated training budget, regul

Account Director, Medical Education: Salary TBC

Scientific Director: £60000 - £85000 per annum, Benefits: Bonus, pension, subsidised gym and much more

Account Manager (PR): Great Benefits

Publications director: Competitive salary and bonus scheme

Account Manager: £Competitive Salary

Senior Medical Writer or Lead Medical Writer: £Competitive Salary

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Account Director, Healthcare Communications: Salary TBC

Senior External Communications Lead: £Competitive Salary

Brand Manager - Medium Global Pharma Company: £Competitive Financial Package

Senior Medical Writer, MedComms Agency: Salary TBC

Account director: Competitive salary and bonus scheme

Digital Associate Director - Medcomms: £65000 - £80000 per annum

Subscribe to our email news alerts

No results were found

PMHub

Add my company

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

20 for 2020 – Five pharma companies to watch: As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs): Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...
The roaring ‘20s and Generation Z: How a new generation will shape pharma comms this decade...